Market Overview:
The global activated partial thromboplastin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, rising demand for point-of-care testing, and technological advancements in activated partial thromboplastin assay kits. Based on type, the global activated partial thromboplastin market is segmented into active electrode, dispersive electrode, and others. The active electrode segment is expected to account for the largest share of the global activated partial thromboplastin market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030.
Product Definition:
A clotting factor that is activated by thrombin and helps to form clots.
Active Electrode:
Active electrode is a kind of heparin-based drug which increases the blood flow to vital organs by reducing the blood coagulation. It also helps in increasing the partial thromboplastin time, which further enhances the platelet aggregation and allows more time for clots to dissolve.
Dispersive Electrode:
Dispersive Electrode is a new technology developed to overcome limitations of other thromboplastin devices. It allows rapid and accurate measurement of activated partial thromboplastin (aPTT) in patients with suspected acute coronary syndrome (ACS) or myocardial infarction. The Dispersive Electrode helps in the early diagnosis and management of cardiovascular diseases by providing accurate, sensitive, and reliable results for the quantitative determination of aPTT.
Application Insights:
Based on application, the global activated partial thromboplastin market is segmented into hospitals, diagnostic centers, specialty clinics and emergency ambulatory care. Hospitals dominated the market in 2017 owing to increasing prevalence of coagulation disorders and rising number of trauma cases. According to a study published by National Center for Biotechnology Information (NCBI) in 2018, around 10-20% patients presenting with acute coronary syndrome will develop complications due to fibrinolysis-related death or permanent disability. Therefore, it can be concluded that there is huge unmet clinical need for anticoagulants across the globe which will drive demand over the forecast period.
The specialty clinics are expected to witness lucrative growth during the forecast period as these facilities focus on providing quality healthcare services at an affordable cost which attracts a large patient base from low-income groups looking for treatment at reasonable costs without compromising with their health & wellness standards & preferences.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate of technologically advanced products are some factors driving the regional growth. Moreover, increasing road accidents and trauma cases are also contributing to the demand for ATPlite in North America.
In addition, rapidly developing healthcare infrastructure along with supportive government initiatives will drive industry expansion over this region.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global activated partial thromboplastin market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of thrombotic disorders such as deep vein thrombosis, pulmonary embolism, and myocardial infarction.
- Growing geriatric population: The geriatric population is more susceptible to developing blood clots and hence, the demand for activated partial thromboplastin is expected to increase in this population segment over the next few years.
- Rising awareness about early diagnosis and treatment: There has been an increase in awareness about early diagnosis and treatment of blood clotting disorders in recent years which is likely to boost the demand for activated partial thromboplastin products over the forecast period.
- Technological advancements: The development of novel technologies for detecting blood clots at an early stage will fuel growth opportunities for players operating in this market during the forecast period. For instance, Siemens Healthcare Diagnostics recently launched a new Activated Partial ThromboPlastin Time (aPTT) assay that helps clinicians detect hypercoagulable states with increased accuracy and precision using only a small amount of patient plasma sample volume (
Scope Of The Report
Report Attributes
Report Details
Report Title
Activated Partial Thromboplastin Market Research Report
By Type
Active Electrode, Dispersive Electrode, Others
By Application
Hospitals, Diagnostic Centers, Specialty Clinics, Emergency Ambulatory Cente
By Companies
Boston Scientific, McKesson Corporation, Symmetry Surgical, World Precision Instruments, Medline Industries, Medtronic, Erbe Elektromedizian Gmbh, Smith and Nephew, Olympus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Activated Partial Thromboplastin Market Report Segments:
The global Activated Partial Thromboplastin market is segmented on the basis of:
Types
Active Electrode, Dispersive Electrode, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Specialty Clinics, Emergency Ambulatory Cente
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- McKesson Corporation
- Symmetry Surgical
- World Precision Instruments
- Medline Industries
- Medtronic
- Erbe Elektromedizian Gmbh
- Smith and Nephew
- Olympus
Highlights of The Activated Partial Thromboplastin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Active Electrode
- Dispersive Electrode
- Others
- By Application:
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Emergency Ambulatory Cente
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Activated Partial Thromboplastin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Activated partial thromboplastin (APT) is a blood clotting factor that helps to prevent blood clots from forming in the veins. APT is produced by the body when it detects a blood clot.
Some of the major companies in the activated partial thromboplastin market are Boston Scientific, McKesson Corporation, Symmetry Surgical, World Precision Instruments, Medline Industries, Medtronic, Erbe Elektromedizian Gmbh, Smith and Nephew, Olympus.
The activated partial thromboplastin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Activated Partial Thromboplastin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Activated Partial Thromboplastin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Activated Partial Thromboplastin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Activated Partial Thromboplastin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Activated Partial Thromboplastin Market Size & Forecast, 2018-2028
4.5.1 Activated Partial Thromboplastin Market Size and Y-o-Y Growth
4.5.2 Activated Partial Thromboplastin Market Absolute $ Opportunity
Chapter 5 Global Activated Partial Thromboplastin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Activated Partial Thromboplastin Market Size Forecast by Type
5.2.1 Active Electrode
5.2.2 Dispersive Electrode
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Activated Partial Thromboplastin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Activated Partial Thromboplastin Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Specialty Clinics
6.2.4 Emergency Ambulatory Cente
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Activated Partial Thromboplastin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Activated Partial Thromboplastin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Activated Partial Thromboplastin Analysis and Forecast
9.1 Introduction
9.2 North America Activated Partial Thromboplastin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Activated Partial Thromboplastin Market Size Forecast by Type
9.6.1 Active Electrode
9.6.2 Dispersive Electrode
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Activated Partial Thromboplastin Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Specialty Clinics
9.10.4 Emergency Ambulatory Cente
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Activated Partial Thromboplastin Analysis and Forecast
10.1 Introduction
10.2 Europe Activated Partial Thromboplastin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Activated Partial Thromboplastin Market Size Forecast by Type
10.6.1 Active Electrode
10.6.2 Dispersive Electrode
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Activated Partial Thromboplastin Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Specialty Clinics
10.10.4 Emergency Ambulatory Cente
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Activated Partial Thromboplastin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Activated Partial Thromboplastin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Activated Partial Thromboplastin Market Size Forecast by Type
11.6.1 Active Electrode
11.6.2 Dispersive Electrode
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Activated Partial Thromboplastin Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Specialty Clinics
11.10.4 Emergency Ambulatory Cente
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Activated Partial Thromboplastin Analysis and Forecast
12.1 Introduction
12.2 Latin America Activated Partial Thromboplastin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Activated Partial Thromboplastin Market Size Forecast by Type
12.6.1 Active Electrode
12.6.2 Dispersive Electrode
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Activated Partial Thromboplastin Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Specialty Clinics
12.10.4 Emergency Ambulatory Cente
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Activated Partial Thromboplastin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Activated Partial Thromboplastin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Activated Partial Thromboplastin Market Size Forecast by Type
13.6.1 Active Electrode
13.6.2 Dispersive Electrode
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Activated Partial Thromboplastin Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Specialty Clinics
13.10.4 Emergency Ambulatory Cente
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Activated Partial Thromboplastin Market: Competitive Dashboard
14.2 Global Activated Partial Thromboplastin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 McKesson Corporation
14.3.3 Symmetry Surgical
14.3.4 World Precision Instruments
14.3.5 Medline Industries
14.3.6 Medtronic
14.3.7 Erbe Elektromedizian Gmbh
14.3.8 Smith and Nephew
14.3.9 Olympus
